Dr Akle recalls his own experiences as a doctor and how this has lead him to research the relationship between immunology and cancer treatment.

Dr Charles Akle is the founder and CEO of Immodulon Therapeutics which he established in 2007 with the philanthropic support of a former patient. His ambition from the start was to bring to market an affordable immunotherapy treatment that would transform the way that cancer is treated in the world today. Since then, Immodulon has become a leading independent biopharmaceutical company with one of the longest running research projects in this area. Charles received his medical training at Guy’s Hospital in London and acted as a leading surgeon for more than 30 years, pioneering the innovation of laparoscopic surgery which established minimally invasive procedures as an alternative to major operations.

This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at [ Ссылка ]

свернуть